SART3 anticorps (C-Term)
Aperçu rapide pour SART3 anticorps (C-Term) (ABIN374289)
Antigène
Voir toutes SART3 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- C-Term
-
Séquence
- C-MSNADFAKLF LRK
-
Specificité
- This antibody detects SART3 at C-term.
-
Réactivité croisée (Details)
- Species reactivity (tested):Human
-
Purification
- Ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide
-
Immunogène
- Peptide from C Terminus of the protein sequence according to NP_055521.1 Genename: SART3
-
-
-
-
Indications d'application
-
Peptide ELISA: Limit dilution 1: 16000. Western blot: 0.01-0.03 μg/mL. Approx 170 kDa band observed in lysates of cell lines Daudi,Jurkat and MOLT4 (calculated MW of 110 kDa according to NP_055521.1). The observedmolecular weight corresponds to earlier findings in literature with different antibodies(Yang et al, Cancer Res.1999 Aug 15,59(16): 4056-63, PMID: 10463607).
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. -
Restrictions
- For Research Use only
-
-
-
Concentration
- 0.5 mg/mL
-
Buffer
- Tris saline, 0.02 % sodium azide, pH 7.3 with 0.5 % bovine serum albumin
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Conseil sur la manipulation
- Avoid repeated freezing and thawing.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 2 - 8 °C for up to one month or (in aliquots) at -20 °C.
-
-
- SART3 (Squamous Cell Carcinoma Antigen Recognized By T Cells 3 (SART3))
-
Autre désignation
- SART3 / TIP110
-
Sujet
- Synonyms: KIAA0156, SART-3, Squamous cell carcinoma antigen recognized by T-cells 3, Tat-interacting protein of 110 kDa
-
ID gène
- 9733
-
NCBI Accession
- NP_055521
-
UniProt
- Q15020
-
Pathways
- Ribonucleoprotein Complex Subunit Organization
Antigène
-